DocDollars

Albireo Pharma, Inc.

MA · United States · Reporting entity ID 100001056884

Total reported 2019–2025
$8.45M
#548 of 2,960 reporting companies — 0% of all reported industry payments
$1.14M in general payments across 1,453 records, plus $7.31M in research funding across 1,720 records.

How it breaks down

General payments $1,137,386
Research funding $7,309,616

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Albireo Pharma, Inc. reported $8.45M to US doctors and teaching hospitals from 2019 to 2025, ranking #548 of 2,960 reporting companies. 87% of that was research funding and 13% general payments such as consulting, speaking, food and travel. 1,453 general payment records and 1,720 research records were filed.

Common questions about Albireo Pharma, Inc.

How much has Albireo Pharma, Inc. paid US doctors?

Albireo Pharma, Inc. reported $8,447,002 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,137,386 in general payments, $7,309,616 in research funding.

How does Albireo Pharma, Inc. rank among drug and device companies?

It ranks #548 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Albireo Pharma, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.